A subpopulation of 7-day old neonatal rat ventricular cardiomyocytes retains the inherent ability to re-enter the cell cycle delineated by the de novo nestin expression
{"title":"A subpopulation of 7-day old neonatal rat ventricular cardiomyocytes retains the inherent ability to re-enter the cell cycle delineated by the de novo nestin expression","authors":"Adrien Aubry , Patrice Naud , Leblanc Charles-Alexandre , Angelino Calderone","doi":"10.1016/j.acvd.2025.03.034","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Studies have reported that injury to the 7-day old neonatal rodent heart failed to elicit a regenerative response. It remains presently unknown whether the latter paradigm is attributed in part to an inherent loss of ventricular cardiomyocytes to re-enter the cell cycle.</div></div><div><h3>Objective</h3><div>To examine whether 7-day old neonatal rat ventricular cardiomyocytes can re-enter the cell cycle and express a pattern of gene expression associated with a potential cardiac regenerative response.</div></div><div><h3>Method</h3><div>Ventricular cardiomyocytes (NNVMs) were isolated from 7-day old neonatal Sprague-Dawley rats and treated for 3 days with the phorbol ester phorbol 12,13 dibutyrate (PDBu; 100<!--> <!-->nM) in the absence or presence of the p38a/b MAPK inhibitor SB203580 (10<!--> <!-->mM). Cell cycle re-entry and gene expression was determined by QPCR and Bulk RNA Seq Analysis. Partial apex resection of the 7-day old neonatal rat heart was performed and pups sacrificed 3 days later.</div></div><div><h3>Results</h3><div>80% of the population of untreated 7-day old NNVMs were mononucleated. PDBu treatment for 3-days failed to promote cell cycle re-entry but induced a hypertrophic response delineated by a significant upregulation of Nppa and Nppb mRNAs. SB203580 administration to PDBu treated NNVMs translated to cell cycle re-entry characterized by nuclear 5-bromo-2′-deoxyuridine incorporation and nuclear staining of phosphorylated serine10 of histone 3 of a subpopulation characterized by de novo expression of the intermediate filament protein nestin. The latter paradigm was confirmed by Western blot and QPCR. The appearance/cell cycle re-entry of nestin (+)-NNVMs was associated with a significant mRNA upregulation of a panel of glycolytic enzymes (PDK3, PFKP, PKM, Slc2a1) and concomitant reduction of enzymes implicated in fatty acid oxidation (Cpt1b, Sdha, Acsl1). Three days following partial apex-resected 7-day old neonatal rat heart, the appearance of a subpopulation of NNVMs associated with de novo nestin expression was identified adjacent to the damaged region and significantly re-entered the S-phase and G2-M phase of the cell cycle.</div></div><div><h3>Conclusion</h3><div>A subpopulation of 7-day old neonatal rat ventricular cardiomyocytes possess the inherent ability to re-enter the cell cycle in vitro and in vivo characterized by the selective expression of the intermediate filament protein nestin.</div></div>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":"118 6","pages":"Pages S187-S188"},"PeriodicalIF":2.3000,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Cardiovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1875213625001299","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Studies have reported that injury to the 7-day old neonatal rodent heart failed to elicit a regenerative response. It remains presently unknown whether the latter paradigm is attributed in part to an inherent loss of ventricular cardiomyocytes to re-enter the cell cycle.
Objective
To examine whether 7-day old neonatal rat ventricular cardiomyocytes can re-enter the cell cycle and express a pattern of gene expression associated with a potential cardiac regenerative response.
Method
Ventricular cardiomyocytes (NNVMs) were isolated from 7-day old neonatal Sprague-Dawley rats and treated for 3 days with the phorbol ester phorbol 12,13 dibutyrate (PDBu; 100 nM) in the absence or presence of the p38a/b MAPK inhibitor SB203580 (10 mM). Cell cycle re-entry and gene expression was determined by QPCR and Bulk RNA Seq Analysis. Partial apex resection of the 7-day old neonatal rat heart was performed and pups sacrificed 3 days later.
Results
80% of the population of untreated 7-day old NNVMs were mononucleated. PDBu treatment for 3-days failed to promote cell cycle re-entry but induced a hypertrophic response delineated by a significant upregulation of Nppa and Nppb mRNAs. SB203580 administration to PDBu treated NNVMs translated to cell cycle re-entry characterized by nuclear 5-bromo-2′-deoxyuridine incorporation and nuclear staining of phosphorylated serine10 of histone 3 of a subpopulation characterized by de novo expression of the intermediate filament protein nestin. The latter paradigm was confirmed by Western blot and QPCR. The appearance/cell cycle re-entry of nestin (+)-NNVMs was associated with a significant mRNA upregulation of a panel of glycolytic enzymes (PDK3, PFKP, PKM, Slc2a1) and concomitant reduction of enzymes implicated in fatty acid oxidation (Cpt1b, Sdha, Acsl1). Three days following partial apex-resected 7-day old neonatal rat heart, the appearance of a subpopulation of NNVMs associated with de novo nestin expression was identified adjacent to the damaged region and significantly re-entered the S-phase and G2-M phase of the cell cycle.
Conclusion
A subpopulation of 7-day old neonatal rat ventricular cardiomyocytes possess the inherent ability to re-enter the cell cycle in vitro and in vivo characterized by the selective expression of the intermediate filament protein nestin.
期刊介绍:
The Journal publishes original peer-reviewed clinical and research articles, epidemiological studies, new methodological clinical approaches, review articles and editorials. Topics covered include coronary artery and valve diseases, interventional and pediatric cardiology, cardiovascular surgery, cardiomyopathy and heart failure, arrhythmias and stimulation, cardiovascular imaging, vascular medicine and hypertension, epidemiology and risk factors, and large multicenter studies. Archives of Cardiovascular Diseases also publishes abstracts of papers presented at the annual sessions of the Journées Européennes de la Société Française de Cardiologie and the guidelines edited by the French Society of Cardiology.